About this trial
TARGET-AUTOIMMUNE is an observational research study to conduct a comprehensive review of outcomes for patients with autoimmune and related diseases. .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Death
Manual removal (sponsor or site request)
No EHR interface encounter > 3 years
Adult patients diagnosed and managed for these conditions invited to participate
Trial population
The study will include adults who are being managed for autoimmune disease
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
To characterize the natural history of disease in patients with autoimmune disease of various etiologies.
To assess safety and effectiveness of autoimmune disease treatments and treatments for complications of any related conditions
Secondary outcomes
To evaluate provider management practices in the treatment of patients with autoimmune diseases
Health care provider type, clinic setting, reason for initiating/not initiating/adjusting dosing of treatments, reason for discontinuing/switching treatments, and monitoring outcomes on and off treatment, will be captured as available in the provided EHR and/or through linked data. Disease-specific quality measures will be selected and evaluated.
To evaluate longitudinal and patient reported outcomes in patients with autoimmune diseases
Longitudinal clinical outcomes and disease progression will be assessed. Self-reported patient health measures collect information directly from patients to measure physical, mental, and social health. These measures can help clinicians better understand how the disease state and/or various treatments affect what patients are able to do and the symptoms they experience beyond what is typically derived and reported in the EHR as part of traditional clinical evaluations. The information can also be used to help patients make informed decisions about their healthcare and treatment options.
To select and evaluate quality of care measures for patients with autoimmune diseases
1. Identify and select best practices in care of patients with autoimmune diseases 2. Develop a technology infrastructure to evaluate quality measures to support clinicians.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: